Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome

Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome

AIM: To estimate the prevalence of plasminogen activator inhibitor type 1 (PAI-1) gene polymorphism in patients with antiphospholipid syndrome (APS) and its implication in vascular disorders/MATERIAL AND METHODS: The investigation enrolled 138 patients: 103 with APS, including 47 with systemic lupus...

Full description

Bibliographic Details
Main Authors: T M Reshetniak, E V Ostriakova, N L Patrusheva2, L I Patrushev, E N Aleksandrova, N V Seredavkina, A V Volkov, E L Nasonov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2013-01-01
Series:Терапевтический архив
Subjects:
plasminogen activator inhibitor type 1 gene polymorphism
thrombosis
antiphospholipid syndrome
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31214

Internet

https://ter-arkhiv.ru/0040-3660/article/view/31214

Similar Items